4.7 Article

Synthesis and antibacterial activity of Schiff bases of 5-substituted isatins

期刊

CHINESE CHEMICAL LETTERS
卷 27, 期 2, 页码 221-225

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cclet.2015.10.027

关键词

Synthesis; Isatin; Schiff base; Hydantoin; Antibacterial

向作者/读者索取更多资源

Based on the existing reports on the bioactive isatin derivatives, a number of Schiff bases were synthesized by reacting 5-substituted isatins with bioactive amines/hydrazides and their structures were confirmed using spectroscopic methods such as NMR, IR and mass spectrometry. Furthermore, N-benzylation of isatin followed by the Schiff base formation furnished a new series of compounds (11a-13c) which allowed the analysis of the effect of isatin N-substitution on the bioactivity of the resulting compounds. The antibacterial activity of the synthesized derivatives was evaluated using a microtiter plate method on a series of gram positive and gram negative bacterial strains. Compounds 2d, 3b, 5c and 6a were among the most potent derivatives against Pseudomonas aeruginosa (MIC = 6.25 mu g/mL). Analysis of the structure-activity relationship showed that the incorporation of (thio)urea-based Schiff bases lead to more potent derivatives with a broader spectrum of antibacterial activity. In addition, highly lipophilic compounds such as 11a-12c did not show any measurable antibacterial activity, which implies that an optimal lipophilicity might be an important requirement for the antibacterial activity of the studied isatins. Finally, the finding that hydantoin derivatives of N-benzylisatins (13a-13c) still exhibit some antibacterial activity prompted us to consider exploring the bioactivity of more diverse derivatives of isatin-aminohydantoin Schiff bases (compounds 1a-1d) in our future studies. (C) 2015 Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据